Clinical Research Directory
Browse clinical research sites, groups, and studies.
Lithium Treatment to Prevent Cognitive Impairment After Brain Radiotherapy
Sponsor: Region Stockholm
Summary
Randomized, placebo-controlled, double-blinded, parallel group clinical trial to investigate if 6 months of oral lithium tablets (S-lithium 0,5-1,0 mmol/l) will prevent cognitive decline after brain radiotherapy in pediatric brain tumor survivors. Primary outcome measure is Processing Speed Index (PSI) 2 years after start of study treatment.
Key Details
Gender
All
Age Range
5 Years - Any
Study Type
INTERVENTIONAL
Enrollment
84
Start Date
2024-02-16
Completion Date
2033-08-31
Last Updated
2024-04-12
Healthy Volunteers
No
Conditions
Interventions
Lithium
Lithium sulphate, 42 mg (6 mmol lithium)
Placebo
White round tablet, 10 mm. Identical to experimental drug (lithium)
Locations (2)
Karolinska Universitetssjukhuset
Solna, Stockholm County, Sweden
HOPE
Stockholm, Sweden